Revolutionary Hearing Test Set To Turn Heads With Archangels’ Investment

Revolutionary Hearing Test Set To Turn Heads With Archangels' Investment We are delighted to announce that we completed our first funding round lead by Archangels, including Equity Gap and private investors, and welcome our new board members, Charles Sweeney (NXD Chairman), Jaqcui McLaughlin (Investor Director + NXD), and Phil Harris (NXD)! We are looking forward …

Hearing Diagnostics selected for Unlocking Ambition Cohort 2!

Hearing Diagnostics selected for Unlocking Ambition Cohort 2! We're absolutely delighted to announce that we've been selected to participate in the Unlocking Ambition cohort 2! The programme will accelerate our growth towards ensuring hearing testing becomes more accessible and accurate, ensuring everyone receives care at the earliest opportunity. We're excited to start the programme and meet …

Recipients of the Innovate UK grant for business-led innovation in response to global disruption 

We're delighted to announce that we've been selected by Innovate UK to receive grant funding as part of the business-led response to global disruption due to Covid-19. For more information on how our hearing testing technology Audimetroid will contribute towards improving lives of individuals with hearing loss in times of the pandemic, please get in …

Phil Harris joins Hearing Diagnostics in the role of Non-Executive Director

We're delighted to announce that Philip Harris will be joining us as non-executive director. Phil has a wealth of experience as CEO in medical devices and manufacturing/engineering companies and is passionate about driving change in healthcare. We're very excited to welcome him on board and are looking forward to working together to lead innovation in …